The classically de®ned induction of the liver from the endoderm, elicited by the cardiac mesoderm, has recently been discovered to involve signaling by ®broblast growth factors (FGFs). Multiple FGFs induce hepatic gene expression independent of an effect on growth. A subset of these FGFs cooperates with other factors to promote morphogenesis of the newly speci®ed hepatocytes. Subsequent to the formation of the liver bud, distinct mesenchymal signals and hepatic response pathways stimulate further growth and differentiation of the hepatic parenchymal cells and prevent apoptosis. The initial stages of hepatogenesis are therefore beginning to be understood, and serve as a paradigm for the development of other tissues from the endoderm. q
Introduction
The study of liver development is entering an exciting phase. The classical embryonic liver induction events that were discovered by LeDouarin over 30 years ago (LeDouarin, 1965) are now being understood in mechanistic detail. As will be described below, the recent discovery of molecules that elicit the embryonic induction of the liver bud has revealed an unexpected complexity in signaling events. Furthermore, inactivation of genes for transcription and signaling factors in mice has uncovered a series of intercellular interactions that occur subsequent to the liver bud and are important for early liver growth and hepatocyte differentiation. While the unique requirements of hepatocyte differentiation would suggest that the underlying mechanisms might be speci®c to that cell type, the critical regulatory proteins that will be discussed in this review are expressed during the development of other tissues. Since the liver functions as a site of hematopoiesis in the embryo, prior to the onset of function of many other organs, it is not surprising that widely expressed genes elicit early fetal liver phenotypes when they are knocked out in mice. Thus, it seems likely that the roles of signaling and transcription factors in liver development will provide insight into what these factors do in other developmental contexts. This review will cover the latest ®ndings on early liver development and illustrate how the underlying mechanisms may be of general signi®cance.
The basics of early liver development
The liver emerges from the de®nitive gut endoderm ®rst as a thickening of the ventral endodermal epithelium and then as a bud of cells that proliferate and migrate into the surrounding septum transversum mesenchyme, all within the 12±25 somite stage (Fig. 1A,B) . The nascent hepatocytes appear to surround spaces within the septum transversum mesenchyme and the entire domain becomes delineated or encapsulated as the liver bud grows rapidly into an organ (Fig. 1C) . The general architecture of the liver is laid down at this point, as the mesenchymal spaces will become the liver sinusoids through which blood cells traverse. During fetal life, the liver is the prominent site of hematopoiesis and up to 60% of the liver mass consists of blood cells (Paul et al., 1969) . During the perinatal period, a large number of metabolic enzymes are induced within the hepatocytes as the hematopoietic cells migrate elsewhere and the liver prepares to control metabolite and serum protein levels in the blood, store glycogen, and detoxify. This review will focus on the earliest stages of liver development, including the speci®cation of the endodermal domain that will become the liver, the proliferation of cells to form the liver bud, and the initial stages of morphogenesis of the liver bud into an organ.
Competence for liver development in the ventral foregut endoderm
Before considering hepatic speci®cation in detail, it is worth noting that although many gene knockouts in mice affect tissues derived from the endoderm, none affect the initial speci®cation. Relevant tissues include the liver, the lung, the thyroid, the pancreas, the intestine, and the stomach. Genes have been found to be essential for the development of large portions of the endoderm itself, or for organogenesis after the tissue bud stage. However, no genes have been found to be critical for the expression of the earliest known liver markers or for the initial budding of the aforementioned tissues from the endoderm. It seems possible that the relevant signaling molecules and transcription factors are redundant. An alternative scenario is presented below.
While the secrets of endoderm tissue speci®cation have eluded mouse genetics, embryo tissue transplant and explant studies have been illuminating. Classical transplantation studies performed by LeDouarin (1965) showed that in the chick, the cardiac mesoderm induces the liver in the adjacent, prospective ventral foregut domain of endoderm at about the 6 somite stage. Mesoderm from other domains of the chick embryo does not induce the liver, and the prospective dorsal endoderm, which normally gives rise to the intestine, is not hepatogenic. This latter point indicates that there is likely to be a pre-pattern or competence of the ventral foregut to either receive the cardiac signal or express the hepatic program, or both (Fig. 1A) .
Among the transcription factors found to be expressed in the de®nitive (embryonic) endoderm, the transcription factors HNF3b and GATA-4 have each been found to be necessary for the development of the ventral foregut endoderm (Ang and Rossant, 1994; Weinstein et al., 1994; Kuo et al., 1997; Molkentin et al., 1997) and both of these factors are important for hepatic gene expression. A speci®c role for these factors in potentiating hepatic gene expression in the endoderm has been proposed (Bossard and Zaret, 1998; Zaret, 1999) . Whatever the underlying mechanism, the requirement for homologues of these winged-helix and zinc-®nger proteins in the development of gut-derived tissues in worms,¯ies, frogs, and mice (see Zaret, 1999) indicates that they have an evolutionarily conserved role in establishing the developmental competence of the endoderm.
FGF signaling and liver speci®cation
The reconstitution of hepatic speci®cation with mouse embryo explants in vitro has recently led to the discovery of signals from the cardiac mesoderm that can specify the liver. Using a tissue explant assay, Gualdi et al. (1996) found that the ventral foregut endoderm in the mouse becomes speci®ed to express hepatic genes during the 7±8 somite stage, similar to the stage observed in the chick. Close proximity to the cardiac mesoderm in vitro leads to the induction of hepatic genes in the ventral foregut endoderm, when the tissues are isolated from the 2±6 somite stages (Fig. 1B) . Furthermore, cardiac mesoderm induces dramatic outgrowth of the endodermal epithelium in vitro, mimicking the rapid outgrowth of cells within the liver bud in the embryo. The ability to reconstitute hepatic gene induction and morphogenetic outgrowth responses to the cardiac mesoderm set the stage to identify signals within the cardiac tissue that are hepatogenic to the endoderm.
Fibroblast growth factors (FGFs) are secreted molecules that promote morphogenetic budding from epithelia in a variety of developmental contexts, including limb buds, and branching in the embryonic lung, and the determination of sites of tooth budding (see recent reviews by Yamaguchi and Rossant, 1995; Hogan, 1999) . Up to 18 FGFs are known, and some, including FGF-18, stimulate hepatocyte proliferation in adult livers (e.g. Hu et al., 1998) . There are four FGF receptors, some of which exhibit alternatively spliced isoforms, and their cytoplasmic domains possess tyrosine kinase activity and stimulate the mitogen activated protein kinase pathway (Green et al., 1996) . Different FGF receptors each bind different, overlapping subsets of FGFs (Wang et al., 1994) . At the time of hepatogenesis, the endoderm uniquely expresses FGF receptor 4 (FGFR-4) (Stark et al., 1991) and both the endoderm and cardiac mesoderm express FGF receptor 1 (Sugi and Lough, 1995) . Gene knockout studies in mice showed that FGFR-1 is intrinsically required for endoderm development (Ciruna et al., 1997) , whereas FGFR-4 inactivation has no embryological phenotype, suggesting redundancy (Weinstein et al., 1998) .
In situ immunohistochemistry analysis showed that FGF1 and FGF2 are both induced in the cardiac mesoderm at the 7±8 somite stages (Jung et al., 1999) . Crossley and Martin (1995) showed that FGF8 mRNA is expressed highly in the cardiac mesoderm at early somitic stages, and though it declines by the 7±8 somite stages, considerable FGF8 protein remains at the junction between the cardiac mesoderm and the ventral foregut endoderm (Jung et al., 1999) . Thus, at least three FGF proteins are produced by the cardiac mesoderm at the time of hepatogenesis (Fig. 2) . Homozygous inactivation of FGF8 is embryonic lethal prior to hepatogenesis (Meyers et al., 1998) , whereas inactivation of FGF2 causes cerebral defects but not lethality (Dono et al., 1998; Ortega et al., 1998) .
Puri®ed FGF1 and FGF2 were each found to ef®ciently induce early liver-speci®c genes within the ventral foregut endoderm, when the endoderm was isolated from the 2±6 somite stages. The induction of these genes, including serum albumin, a-fetoprotein, and transthyretin, was as robust as that elicited by the cardiac mesoderm (Jung et al., 1999) . FGF8 had only partial hepatogenic activity, and other tyrosine kinase signaling molecules such as EGF had no activity (Jung et al., unpublished data) . Soluble, dominant negative inhibitors of FGF signaling ef®ciently blocked hepatic gene induction in co-cultures of cardiac mesoderm and ventral foregut endoderm (Jung et al., 1999) . Taken together, these studies showed that redundant FGF signaling is both necessary and suf®cient to induce hepatic differentiation within the endoderm (Fig. 3A) . Clearly it will be important to con®rm this conclusion with compound homozygous FGF mutant embryos. The existence of multiple FGFs in the cardiac mesoderm as well as the redundancy of FGF receptors in the endoderm will render such a genetic analysis daunting to perform.
Signaling complexity in generating the liver bud
The FGF experiments with endoderm explants described above yielded unexpected observations. First, in the endoderm explant assay, FGF1 and FGF2 ef®ciently induced hepatic gene expression in the ventral foregut endoderm, but in isolation the factors did not induce proliferation or budding morphogenesis (Jung et al., 1999) . However, as noted above, cardiac mesoderm induces a strong morphogenetic response in the hepatic endoderm in vitro. Thus, distinct signals from the cardiac mesoderm must be morphogenetic. Interestingly, a particular dominant negative inhibitor of FGF signaling, based on a fusion between the extracellular domain of FGF receptor 4 and the dimerization domain of immunoglobulin G, effectively inhibited the morphogenetic outgrowth of the endoderm in the explant assay. Excess FGF8, added back to the FGFR-4±IgG treated cultures, restored morphogenetic outgrowth (Jung et al., 1999) . Because FGF8 alone was not morphogenetic, these ®ndings indicate that either FGF8, or different cardiac FGF that binds FGF receptor 4 (Fig. 3B, solid arrow) , work in conjunction with another, unknown cardiac factor (Fig. 3B , dashed arrow) to promote early hepatic morphogenesis. It is notable that the growth signals are experimentally separable from the FGF signal that induces hepatic gene expression.
In summary, these studies revealed a remarkable signaling complexity in generating the liver bud. The in vitro explant assay indicates that two FGF signals promote hepatic differentiation and outgrowth of the endoderm, and that the latter response requires yet a third, as yet unknown signal.
Separable growth phases during expansion of the liver bud
After the liver bud is generated, when morphogenetic extension of the foregut pulls the liver region to the midgut (Fig. 3C) , it seems that a distinct group of growth signaling pathways takes over. This conclusion is drawn from gene knockout studies in mice that result in hypoproliferation of hepatocytes after the liver bud stage. Hepatic proliferation is impaired at different stages in these different mouse mutants, implying further signaling complexity.
Hepatocyte growth factor (HGF) was originally discovered to play a role in regeneration of the adult liver, after partial hepatectomy (see review by Michalopoulos and DeFrances, 1997) . HGF is also expressed in the septum transversum mesenchyme that surrounds the developing liver bud, and c-met, the HGF receptor, is expressed on embryonic hepatocytes Schmidt et al., 1995) . Homozygous inactivation of either the HGF or c-met genes yields an embryonic lethal phenotype between days 13 and 16 of gestation, due to hypoproliferation and apoptosis of the hepatic parenchyma Schmidt et al., 1995) . While these homozygous embryos also have defects in the placenta, their livers appear to be incapable of supporting the required level of hematopoiesis. A similar phenotype is obtained in embryos lacking a functional gene for c-jun (Hilberg et al., 1993) , a transcription factor that is induced by growth signals (Karin et al., 1997) . C-jun mRNA levels are elevated within 30 min of partial hepatectomy in adult livers (Morello et al., 1990) . Signaling from the c-met receptor is mediated in part by activation or elevation of c-jun (Rodrigues et al., 1997; Auer et al., 1998) , and thus it appears that an HGF/c-met/c-jun pathway is critical for early hepatic growth.
The stress signaling kinase SEK1/MKK4 activates the stress-activated protein kinases (SAPK/JNK), which in turn activates c-jun by phosphorylation (Rodrigues et al., 1997) . SEK1 would therefore appear to be within the aforementioned c-met/c-jun pathway in early liver development. However, homozygous inactivation of SEK1 leads to an embryonic liver defect at days 10.5±12.5 of gestation (Nishina et al., 1999) , which is earlier than that observed in the HFG, c-met, or c-jun knockout embryos. The liver bud forms in SEK1 2/2 embryos, but then the hepatocytes undergo massive apoptosis (Nishina et al., 1999) . Thus, while one function of SEK1 may be to activate c-jun, SEK1 appears to activate earlier pathways that are critical to prevent apoptosis in liver development.
A variety of other mouse knockouts result in apoptosis of the liver parenchyma during midgestation. These include mutations of the genes for the IkB kinase b (IKK2; Li et al., 1999) , the RelA subunit of transcription factor NF-kB (Beg et al., 1995) , and the metal-responsive transcription factor MTF-1 (Gu Ènes et al., 1998) . The lack of IKK2 presumably retards both the degradation of IkB and the activation of NF-kB, a regulator of apoptosis. The lethality of IKK2 inactivation could be rescued by the simultaneous inactivation of TNFR1, the tumor necrosis factor-a (TNFa) receptor, suggesting that hepatocyte apoptosis, at least involving the IkB/NF-kB pathway, is induced by TNF-a levels circulating in the embryo (Li et al., 1999) . It is not yet clear why there is such a delicate balance between proliferation and apoptosis for the embryonic growth signaling pathways. The apoptotic phenotype in MTF-1 2/2 embryos presumably relates to the detoxi®cation function of the factor in controlling metal homeostasis and cellular redox state (Gu Ènes et al., 1998) .
Several mesenchymal signals in addition to HGF appear to be critical for early liver growth. Homozygous inactivation of Hlx, a homeobox transcription factor which is normally expressed in the septum transversum mesenchyme, results in embryonic lethality at day 15 of gestation (Hentsch et al., 1996) . Hlx 2/2 embryos exhibit normal differentiation but severe hypoplasia of the hepatic parenchymal cells. Interestingly, there was no evidence of apoptosis in the homozygote livers. These results suggest that Hlx controls the expression of a mesenchymal signaling molecule, probably distinct from HGF, that in turn regulates the growth of embryonic hepatocytes. The Hlx homozygotes exhibited defects in fetal hematopoiesis, but Hlx 2/2 fetal liver cells could reconstitute hematopoiesis in lethally irradiated normal mice (Hentsch et al., 1996) . Thus, the integrity or proliferation of hepatocytes, as maintained by a mesenchymal signal due to Hlx, is required for proper blood cell development in the fetal liver.
Homozygous mutations of the N-myc and jumonji genes, each of which are normally expressed in domains of hepatic mesenchyme, also result in hepatic hypoproliferation (Sawai et al., 1993; Motoyama et al., 1997; Giroux and Charron, 1998) . The speci®c pathways by which these factors act is unknown. Cell structural proteins are also critical for early liver development, as attested by early liver phenotypes in mouse embryos that are homozygous for b1 integrin (Fassler and Meyer, 1995) and keratin 8 (Baribault et al., 1993) . Fig. 3 . Signals for hepatic speci®cation and liver bud outgrowth. Solid arrows, in¯uences of known FGF molecules; dashed arrow, in¯uence of unknown factor whose existence is inferred from the experiments of Jung et al. (1999) . See text for details.
7. Questions for the future 7.1. Hepatic speci®cation A major issue that has not been resolved is to understand which transcription factors are critical for the initial speci®cation of the liver gene program within the endoderm. None of the known liver transcription factors that are activated during early hepatogenesis are individually critical for speci®cation, suggesting that there may be redundancy. An alternative view is that local exposure to signaling molecules, such as FGF, activates transcription factors that are already expressed in a relatively wide domain of endoderm, resulting in local modi®cation of transcription factor activity and the activation of liver genes in a restricted domain of endoderm. By this view, there is no need for special transcription factors or a combination of factors that, in and of itself, determines the liver gene program. The more general endodermal factors might initiate liver-speci®c transcription in what becomes the hepatic domain, and among the genes that are activated would be liver-enriched transcription factors that are critical for secondary phases of hepatic differentiation.
Candidate regulatory proteins for this model include HNF3 and GATA-4, which, as mentioned above, are critical for the development of the ventral foregut endoderm, and Hex. Hex is interesting; it is a homeobox gene whose expression ®rst marks the anterior domain of the mouse embryo, as well as the most anterior domain of the de®nitive endoderm, post-gastrulation (Thomas et al., 1998) . Hex expression, like that of HNF3 and GATA-4, persists in the endoderm region that becomes the liver (Hromas et al., 1993) .
Liver versus pancreas
Another area of future interest is the interrelation between the speci®cation of the liver and the pancreas, as both tissues emerge from the ventral foregut endoderm and are speci®ed at about the same time (LeDouarin, 1965; Wessells and Cohen, 1967; Gualdi et al., 1996) . Note that the pancreas, but not the liver, also emerges separately from the dorsal foregut endoderm. What signaling mechanisms precisely partition the hepatic domain from the pancreatic domain in the ventral endoderm? While the liver and pancreatic buds express different transcription factors and specialized gene products, some gene products are speci®c to both tissues and both tissue buds undergo extensive cell proliferation, emergence from the endodermal epithelium, and invasion of the surrounding mesenchyme. Thus, while the initial triggers of the hepatic and pancreatic programs must be distinct, and probably mutually exclusive, the immediately succeeding signals for morphogenesis may have common elements. A comparative gene array hybridization is being undertaken by several laboratories to understand these differences and commonalities, using PCR-ampli®ed mRNA from different embryonic cell populations. The issue of partitioning of endodermal domains will also apply to the other organs that are derived from the endoderm.
Vasculogenesis
A major concern for liver morphogenesis, as well as for the morphogenesis of other tissues, is the integration of the parenchymal cells with a developing vascular system. Very little is known about how early the endothelial cells become incorporated (the liver bud stage or later?), whether they provide additional growth or differentiation signals for the hepatocytes, and how the apparently chaotic pattern of cell organization in the early liver becomes resolved into a regular array of hepatic plates that are critical to mature liver function. It seems likely that further gene knockout and tissue explant studies with added inhibitors will help answer these questions.
